Daniel Seidl

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort

Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser et al. · European Urology Open Science · 2023 · 41 citations · Full text

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers

Dirk Rades, Daniel Seidl, Stefan Janssen et al. · BMC Cancer · 2016 · 26 citations · Full text

Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN): Is 20 mg/m 2 cisplatin on five days every four weeks an alternative to 100 mg/m 2 cisplatin every three weeks?

Dirk Rades, Daniel Seidl, Stefan Janssen et al. · Oral Oncology · 2016 · 19 citations

Mg/m 2, Radiation Therapy, Medicine +7

Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck

Dirk Rades, Daniel Seidl, Barbara Wollenberg et al. · Anticancer Research · 2016 · 18 citations · Full text

Do we need 5-FU in addition to cisplatin for chemoradiation of locally advanced head-and-neck cancer?

Dirk Rades, Daniel Seidl, Stefan Janssen et al. · Oral Oncology · 2016 · 15 citations

Advanced Head-and-neck Cancer, Radiation Therapy, Medicine +8